These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3747704)

  • 1. Monitoring dapsone self-administration in a multidrug therapy programme.
    van Asbeck-Raat AM; Becx-Bleumink M
    Lepr Rev; 1986 Jun; 57(2):121-7. PubMed ID: 3747704
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of multidrug therapy on the treatment and control of leprosy.
    Gilbody JS
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
    Pieters FA; Woonink F; Zuidema J
    Eur J Clin Pharmacol; 1988; 34(1):73-6. PubMed ID: 3360051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine.
    Leiker DL
    Lepr Rev; 1986; 57 Suppl 3():272-3. PubMed ID: 3573955
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
    [No Abstract]   [Full Text] [Related]  

  • 11. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
    Keeler RF
    Lepr Rev; 1984 Dec; 55(4):391-6. PubMed ID: 6396477
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofazimine and dapsone compliance in leprosy.
    Ellard GA; Pannikar VK; Jesudasan K; Christian M
    Lepr Rev; 1988 Sep; 59(3):205-13. PubMed ID: 3200085
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
    Grosset JH; Baohang J; Noordeen SK
    Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined therapy in leprosy.
    Gatti JC
    Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined chemotherapy of multibacillary leprosy of 6 months' duration.
    Onsun N; Saylan T; Pattyn SR
    Lepr Rev; 1986; 57 Suppl 3():124-6. PubMed ID: 3573952
    [No Abstract]   [Full Text] [Related]  

  • 19. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of different regimens in multibacillary leprosy.
    Pattyn SR
    Lepr Rev; 1986; 57 Suppl 3():265-71. PubMed ID: 3553815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.